BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3100765)

  • 1. Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation.
    Scott JC; Stanski DR
    J Pharmacol Exp Ther; 1987 Jan; 240(1):159-66. PubMed ID: 3100765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil.
    Scott JC; Ponganis KV; Stanski DR
    Anesthesiology; 1985 Mar; 62(3):234-41. PubMed ID: 3919613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
    Cox EH; Kuipers JA; Danhof M
    Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of high-dose alfentanil anaesthesia on the electroencephalogram: correlation with plasma concentrations.
    Bovill JG; Sebel PS; Wauquier A; Rog P; Schuyt HC
    Br J Anaesth; 1983; 55 Suppl 2():199S-209S. PubMed ID: 6418194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical pharmacology of alfentanil.
    Stanski DR
    Eur J Anaesthesiol Suppl; 1987; 1():3-11. PubMed ID: 3126052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alfentanil infusion in the elderly. Prolonged computer-assisted infusion of alfentanil in the elderly surgical patient.
    Lemmens HJ; Bovill JG; Burm AG; Hennis PJ
    Anaesthesia; 1988 Oct; 43(10):850-6. PubMed ID: 3144192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of alfentanil infusions during general anesthesia.
    Shafer A; Sung ML; White PF
    Anesth Analg; 1986 Oct; 65(10):1021-8. PubMed ID: 2875678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect.
    Billard V; Gambus PL; Chamoun N; Stanski DR; Shafer SL
    Clin Pharmacol Ther; 1997 Jan; 61(1):45-58. PubMed ID: 9024173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.
    Cox EH; Kerbusch T; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1095-103. PubMed ID: 9495871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat.
    Mandema JW; Wada DR
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1185-94. PubMed ID: 8531080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil.
    Scott JC; Cooke JE; Stanski DR
    Anesthesiology; 1991 Jan; 74(1):34-42. PubMed ID: 1670913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alfentanil as the last dose (on top) in neuroleptanesthesia with fentanyl. Pharmacokinetics and pharmacodynamics with reference to the cortical effect].
    Freye E; Hartung E; Buhl R
    Anaesthesist; 1986 Apr; 35(4):231-7. PubMed ID: 3087231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age has no effect on the pharmacodynamics of alfentanil.
    Lemmens HJ; Bovill JG; Hennis PJ; Burm AG
    Anesth Analg; 1988 Oct; 67(10):956-60. PubMed ID: 3138925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of alfentanil and etomidate in patients and their relation to compressed power spectral analysis of the EEG.
    Freye E; Hartung E; Klatte A; Abel J
    Acta Anaesthesiol Belg; 1983 Jun; 34(2):87-96. PubMed ID: 6412505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical trial of alfentanil as an adjuvant for short anaesthetic procedures.
    Hull CJ; Jacobson L
    Br J Anaesth; 1983; 55 Suppl 2():173S-178S. PubMed ID: 6418190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
    Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
    Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics of alfentanil: the average dose-plasma concentration relationship and interindividual variability in patients.
    Maitre PO; Vozeh S; Heykants J; Thomson DA; Stanski DR
    Anesthesiology; 1987 Jan; 66(1):3-12. PubMed ID: 3099604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in electroencephalographic bicoherence during sevoflurane anesthesia combined with intravenous fentanyl.
    Morimoto Y; Hagihira S; Yamashita S; Iida Y; Matsumoto M; Tsuruta S; Sakabe T
    Anesth Analg; 2006 Sep; 103(3):641-5. PubMed ID: 16931674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midazolam-alfentanil synergism for anesthetic induction in patients.
    Vinik HR; Bradley EL; Kissin I
    Anesth Analg; 1989 Aug; 69(2):213-7. PubMed ID: 2504079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alfentanil and fentanyl on common bile duct pressure.
    Hynynen MJ; Turunen MT; Korttila KT
    Anesth Analg; 1986 Apr; 65(4):370-2. PubMed ID: 3082247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.